In 2020, the year of the coronavirus SARS-CoV-2 pandemic, resistant bacteria were not found more often in patients in the Netherlands than before the outbreak.

New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw

Worldwide, the number of bacteria resistant to antibiotics is increasing. In the Netherlands, this number generally remains stable and is less high than in many other countries.

During World Antibiotic Awareness Week 2019, RIVM has set up an escape room in one of busiest shopping malls in the Netherlands.

The vaccine against the HPV human papillomavirus virus will also become available for boys.

Antimicrobial resistance is increasing on a global level. It is difficult to treat infections caused by resistant bacteria.

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

ESBL is an enzyme, produced by certain bacteria, which makes these bacteria resistant to antibiotics.

Antimicrobial resistance is a global problem. In the Netherlands, some bacteria that can cause infections in people are more frequently resistant to antibiotics used as a last resort.